Evaluation of the Antifungal Potential of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives Against Candida spp.
Journal of Chemistry · 2026-01 · 2026 (1)
DOI: 10.1155/joch/3054407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemistry, online erschienen am 06.11.2026. Verfasst von Luis Fernando Quejada und 4 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Background
Candidemia and invasive Candidiasis is the most frequent clinical manifestation in immunosuppressed individuals and represents one of the most significant healthcare‐associated infections, with mortality rates ranging from 40% to 60%. Candida albicans remains the most frequently isolated species. However, non‐ albicans species such as C. parapsilosis , C. tropicalis , and C. glabrata have increased in incidence and together represent more than 90% of invasive candidiasis cases. The emergence of resistance to conventional agents such as fluconazole and the limited availability of more potent drugs such as echinocandins and liposomal amphotericin B highlight the need for alternative therapeutic options. Recent studies have reported antiviral and antimicrobial activities of naphthoquinone with aryl‐sulfonamide and sulfonate ester derivatives moieties; however, their action against fungi has rarely been explored.
Objectives
To evaluate the antifungal potential of novel naphthoquinone sulfonamide and sulfonate ester derivatives against Candida spp. and to assess their applicability in experimental treatment.
Methods
Fifteen derivatives were tested. Minimum inhibitory concentration was determined, cytotoxicity assays were performed on mouse peritoneal macrophages, and intracellular reactive oxygen species generation was quantified via confocal microscopy via DCF‐DA.
Results
The PS04 derivative exhibited antifungal activity against C. albicans , C. tropicalis , and C. glabrata at a concentration of 250 µg/mL, while PS01 inhibited C. glabrata at 125 µg/mL. After 24 h of exposure, none of the derivatives caused significant cytotoxicity compared with untreated cells.
Conclusions
PS04 demonstrated promising preliminary antifungal activity against the tested species; however, its mechanism of action remains to be elucidated.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Quejada, L. F., Almeida, R. D., Vericimo, M., Pacheco, P. A. F., & Faria, R. X. (2026). Evaluation of the Antifungal Potential of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives Against Candida spp. Journal of Chemistry, 2026(1). https://doi.org/10.1155/joch/3054407
Vancouver
Quejada LF, Almeida RD, Vericimo M, Pacheco PAF, Faria RX. Evaluation of the Antifungal Potential of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives Against Candida spp. Journal of Chemistry. 2026;2026(1). doi:10.1155/joch/3054407
BibTeX
@article{Quejada2026,
author = {Quejada, Luis Fernando and Almeida, Renata de and Vericimo, Mauricio and Pacheco, Paulo Anastácio Furtado and Faria, Robson Xavier},
title = {Evaluation of the Antifungal Potential of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives Against Candida spp},
journal = {Journal of Chemistry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joch/3054407}
}
EUVIMED